TRAF2 and head and neck carcinoma: Given this cellular behavior of the head and neck carcinoma in which this particular signaling pathway is already activated, it is plausible that NSP 5a3a may be altering this signaling pathway in favor of apoptosis through use of TRAF2 and TRADD.